Tata Chemicals Ltd
Tata Chemicals Ltd Q2 FY26 Results & Concall Highlights: Revenue, Margins & Order Book
Q2 FY26 earnings call: what management guided on revenue, margins and order book.
The short version
Tata Chemicals expects volume growth driven primarily by increased capacity in bicarbonate (bicarb) and further growth in specialty products like FOS (field operation salts). Tata Chemicals expects short-term pressure on soda ash pricing to continue but anticipates market normalization in 18 months due to capacity reconfiguration in Europe and China and easing geopolitical tariff tensions. - Medium-term outlook remains positive driven by growth in solar PV, EV industries, and increasing bicarbonate and silica usage in India. - The company plans capacity expansions in India, including a 15% immediate increase and an additional 35% later, supported by capital raise including Rs.
From Tata Chemicals Ltd's Q2 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Tata Chemicals expects volume growth driven primarily by increased capacity in bicarbonate (bicarb) and further growth in specialty products like FOS (field operation salts).
- Indian market growth remains positive; plans include capacity additions targeting a 15% increase initially, followed by another 35% increase in soda ash capacity.
- The company will focus on capital-efficient and cost-efficient growth, with upcoming capacity expansions in India and silicate capacities at Cuddalore and Mithapur.
- Bicarb is an under-penetrated and growing product in India, with increasing applications beyond flue gas treatment.
- Global soda ash market is oversupplied with pressure on prices, but normalization is expected within 18 months as unremunerative capacities in Europe and China are addressed.
- Supply challenges and tariff frictions are anticipated to ease, supporting stable market conditions going forward.
Profitability & Margins
See what Tata Chemicals Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Tata Chemicals plans capital expenditure around Rs. 1,000 crores for the current year, with updates to be provided in Q3 FY26 results.
- Focus on growing Indian capacity: aiming for a 15% immediate increase followed by an additional 35%, totaling a 50% increase in Indian soda ash capacity.
- Expansion plans include:
- - Adding 500,000 tonnes of soda ash capacity in two phases.
- - Increasing silicate capacity by about 42,000 tonnes in Cuddalore and 60,000 tonnes in Mithapur.
- - Enhancing bicarbonate (bicarb) capacity and FOS (Fast Observed Silica) capacity (5,000 tonnes L55 commissioned recently).
- Proposed Rs. 1,500 crores non-convertible debentures (NCDs) are for general-purpose capital to support these expansion and growth initiatives.
- The company aims to pursue growth in a capital-efficient and cost-effective manner and expects to provide more detailed plans in Q3 FY26.
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Tata Chemicals Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
Tata Chemicals Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹3.4K Cr, net loss ₹2.1K Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Tata Chemicals Ltd's management said in earlier quarters
- Q3 FY26 earnings call analysis →
- Q1 FY27 earnings call analysis →
- Q4 FY26 earnings call analysis →
- Q3 FY25 earnings call analysis →
- Q1 FY26 earnings call →
- Q4 FY25 earnings call →
- Q2 FY25 earnings call →
- Q1 FY25 earnings call →
- Q4 FY24 earnings call →
- Q3 FY24 earnings call →
- Q2 FY24 earnings call →
- Q1 FY24 earnings call →
Others in Chemicals & Petrochemicals this season
- Indian Phosphate Ltd (Q2 FY26)
H1 FY 25-26 revenue increased by ~15% to ₹451 crores versus ₹385 crores in H1 FY 24-25. Key concall takeaways from Indian Phosphate's Q2 FY26 earnings call…
- Alkyl Amines Chemicals Ltd (Q2 FY26)
120 crores. Key concall takeaways from Alkyl Amines Chemicals Ltd's Q2 FY26 earnings call — and how it ranks against sector peers.
- Sudarshan Chemical Industries Ltd (Q2 FY26)
The company completed a significant capex investment of roughly INR 700 crores about 3-4 years ago. Key concall takeaways from Sudarshan Chemical Industries…
- Gujarat Narmada Valley Fertilizers & Chemicals Ltd (Q2 FY26)
Capex pipeline worth INR 2,800 crores includes expansions in AN melt, weak nitric acid, power and steam plant conversion, and ammonia loop expansion. Key…
Frequently Asked Questions
What were Tata Chemicals Ltd Q2 FY26 results?
Tata Chemicals expects volume growth driven primarily by increased capacity in bicarbonate (bicarb) and further growth in specialty products like FOS (field operation salts). Tata Chemicals expects short-term pressure on soda ash pricing to continue but anticipates market normalization in 18 months due to capacity reconfiguration in Europe and China and easing geopolitical tariff tensions. - Medium-term outlook remains positive driven by growth in solar PV, EV industries, and increasing bicarbonate and silica usage in India. - The company plans capacity expansions in India, including a 15% immediate increase and an additional 35% later, supported by capital raise including Rs.
What is Tata Chemicals Ltd share price analysis?
Tata Chemicals Ltd currently shows a neutral. The stock trades at a P/E of N/A with a market cap of ₹16,971 Cr. Investors should review the full earnings analysis for detailed insights.
Is Tata Chemicals Ltd planning capital expenditure?
Tata Chemicals plans capital expenditure around Rs.
Keep Tata Chemicals Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
